58 related articles for article (PubMed ID: 28416640)
1. Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics.
Libera L; Sahnane N; Carnevali IW; Cimetti L; Cerutti R; Chiaravalli AM; Riva C; Tibiletti MG; Sessa F; Furlan D
J Clin Pathol; 2017 Sep; 70(9):792-797. PubMed ID: 28416640
[TBL] [Abstract][Full Text] [Related]
2. Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations.
Nielsen SV; Stein A; Dinitzen AB; Papaleo E; Tatham MH; Poulsen EG; Kassem MM; Rasmussen LJ; Lindorff-Larsen K; Hartmann-Petersen R
PLoS Genet; 2017 Apr; 13(4):e1006739. PubMed ID: 28422960
[TBL] [Abstract][Full Text] [Related]
3. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome.
Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H
J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract][Full Text] [Related]
5. Correlating programmed death ligand 1 (PD-L1) expression, mismatch repair deficiency, and outcomes across tumor types: implications for immunotherapy.
Kim ST; Klempner SJ; Park SH; Park JO; Park YS; Lim HY; Kang WK; Kim KM; Lee J
Oncotarget; 2017 Sep; 8(44):77415-77423. PubMed ID: 29100397
[TBL] [Abstract][Full Text] [Related]
6. Universal molecular screening does not effectively detect Lynch syndrome in clinical practice.
Brennan B; Hemmings CT; Clark I; Yip D; Fadia M; Taupin DR
Therap Adv Gastroenterol; 2017 Apr; 10(4):361-371. PubMed ID: 28491141
[TBL] [Abstract][Full Text] [Related]
7. Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome.
Carnevali I; Libera L; Chiaravalli A; Sahnane N; Furlan D; Viel A; Cini G; Cimetti L; Rossi T; Formenti G; Ghezzi F; Riva C; Sessa F; Tibiletti MG
Int J Gynecol Cancer; 2017 Sep; 27(7):1543-1549. PubMed ID: 28471861
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2.
Haraldsdottir S; Rafnar T; Frankel WL; Einarsdottir S; Sigurdsson A; Hampel H; Snaebjornsson P; Masson G; Weng D; Arngrimsson R; Kehr B; Yilmaz A; Haraldsson S; Sulem P; Stefansson T; Shields PG; Sigurdsson F; Bekaii-Saab T; Moller PH; Steinarsdottir M; Alexiusdottir K; Hitchins M; Pritchard CC; de la Chapelle A; Jonasson JG; Goldberg RM; Stefansson K
Nat Commun; 2017 May; 8():14755. PubMed ID: 28466842
[TBL] [Abstract][Full Text] [Related]
9. Application of Panel-Based Tests for Inherited Risk of Cancer.
Shah PD; Nathanson KL
Annu Rev Genomics Hum Genet; 2017 Aug; 18():201-227. PubMed ID: 28504904
[TBL] [Abstract][Full Text] [Related]
10. Identifying Lynch Syndrome in Women Presenting With Endometrial Carcinoma Under the Age of 50 Years.
Anagnostopoulos A; McKay VH; Cooper I; Campbell F; Greenhalgh L; Kirwan J
Int J Gynecol Cancer; 2017 Jun; 27(5):931-937. PubMed ID: 28498244
[TBL] [Abstract][Full Text] [Related]
11. Incomplete Segregation of MSH6 Frameshift Variants with Phenotype of Lynch Syndrome.
Liccardo R; De Rosa M; Rossi GB; Carlomagno N; Izzo P; Duraturo F
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28481244
[No Abstract] [Full Text] [Related]
12. Inherited mutations in DNA repair genes and cancer risk.
Romero-Laorden N; Castro E
Curr Probl Cancer; 2017; 41(4):251-264. PubMed ID: 28454847
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndrome.
Sunga AY; Ricker C; Espenschied CR; Castillo D; Melas M; Herzog J; Bannon S; Cruz-Correa M; Lynch P; Solomon I; Gruber SB; Weitzel JN
Cancer Genet; 2017 Apr; 212-213():1-7. PubMed ID: 28449805
[TBL] [Abstract][Full Text] [Related]
14. Suspected Lynch syndrome associated MSH6 variants: A functional assay to determine their pathogenicity.
Houlleberghs H; Goverde A; Lusseveld J; Dekker M; Bruno MJ; Menko FH; Mensenkamp AR; Spaander MCW; Wagner A; Hofstra RMW; Te Riele H
PLoS Genet; 2017 May; 13(5):e1006765. PubMed ID: 28531214
[TBL] [Abstract][Full Text] [Related]
15. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
[TBL] [Abstract][Full Text] [Related]
16. Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
Rey JM; Ducros V; Pujol P; Wang Q; Buisine MP; Aissaoui H; Maudelonde T; Olschwang S
J Mol Diagn; 2017 Jul; 19(4):589-601. PubMed ID: 28502729
[TBL] [Abstract][Full Text] [Related]
17. Screening for mismatch repair deficiency in colorectal cancer: data from three academic medical centers.
O'Kane GM; Ryan É; McVeigh TP; Creavin B; Hyland JM; O'Donoghue DP; Keegan D; Geraghty R; Flannery D; Nolan C; Donovan E; Mehigan BJ; McCormick P; Muldoon C; Farrell M; Shields C; Mulligan N; Kennedy MJ; Green AJ; Winter DC; MacMathuna P; Sheahan K; Gallagher DJ
Cancer Med; 2017 Jun; 6(6):1465-1472. PubMed ID: 28470797
[TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Inhibitors in Gynecological Cancers: Update of Literature and Perspectives of Clinical Research.
Gadducci A; Guerrieri ME
Anticancer Res; 2017 Nov; 37(11):5955-5965. PubMed ID: 29061774
[TBL] [Abstract][Full Text] [Related]
19. A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.
Cock-Rada AM; Ossa CA; Garcia HI; Gomez LR
Fam Cancer; 2018 Jan; 17(1):23-30. PubMed ID: 28528518
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Characteristics of Endometrial Cancer in Lynch Syndrome: A French Multicenter Study.
Rossi L; Le Frere-Belda MA; Laurent-Puig P; Buecher B; De Pauw A; Stoppa-Lyonnet D; Canlorbe G; Caron O; Borghese B; Colas C; Delhomelle H; Chabbert-Buffet N; Grandjouan S; Lecuru F; Bats AS
Int J Gynecol Cancer; 2017 Jun; 27(5):953-960. PubMed ID: 28525912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
